[Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization]

Area of Science:

• Endocrinology
• Health Economics

Background:

• Insulin prescription is associated with increased healthcare costs.
• Patient factors significantly influence the economic impact of insulin therapy.

Purpose of the Study:

• To investigate the relationship between patient autonomy and healthcare costs following insulin initiation.
• To identify strategies for cost reduction in insulin management.

Main Methods:

• Analysis of cost data in relation to insulin prescription.
• Evaluation of patient autonomy initiatives.

Main Results:

• Costs following insulin initiation are not solely due to the prescription itself.
• Patient autonomy initiatives show potential for cost reduction.

Conclusions:

• Tailoring patient autonomy programs to individual health profiles, diabetes history, and resources is crucial.
• Empowering patients can mitigate the financial burden of insulin therapy.